Versant Venture Capital Vi, L.P. Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

Versant Venture Capital Vi, L.P. is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 3.73 Million shares of BDTX, which is worth approximately $14.7 Million. The most recent transaction as insider was on Aug 28, 2024, when has been sold 221,600 shares (Common Stock) at a price of $6.32 per share, resulting in proceeds of $1,400,512. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.73M

5.61% 3M change

5.61% 12M change

Total Value Held $14.7 Million

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 28 2024	SELL Open market or private sale	$1,400,512 $6.32 p/Share	221,600 Reduced 5.61%	3,726,341 Common Stock
Nov 27 2020	SELL Other acquisition or disposition	-	394,000 Reduced 9.07%	3,947,941 Common Stock
Nov 23 2020	SELL Other acquisition or disposition	-	476,659 Reduced 9.89%	4,341,941 Common Stock
Nov 19 2020	SELL Open market or private sale	$3,791,330 $33.01 p/Share	114,854 Reduced 2.33%	4,818,600 Common Stock
Nov 18 2020	SELL Open market or private sale	$15,652 $33.09 p/Share	473 Reduced 0.01%	4,933,454 Common Stock
Nov 17 2020	SELL Open market or private sale	$122,450 $33.05 p/Share	3,705 Reduced 0.08%	4,933,927 Common Stock
Nov 16 2020	SELL Open market or private sale	$5,843 $33.01 p/Share	177 Reduced 0.0%	4,937,632 Common Stock
Nov 13 2020	SELL Open market or private sale	$134,832 $33.92 p/Share	3,975 Reduced 0.08%	4,937,809 Common Stock
Nov 12 2020	SELL Open market or private sale	$473,171 $34.34 p/Share	13,779 Reduced 0.28%	4,941,784 Common Stock
Nov 11 2020	SELL Other acquisition or disposition	-	690,814 Reduced 12.23%	4,955,563 Common Stock
Nov 11 2020	SELL Open market or private sale	$383,422 $34.4 p/Share	11,146 Reduced 0.2%	5,646,377 Common Stock
Nov 10 2020	SELL Open market or private sale	$805,388 $33.81 p/Share	23,821 Reduced 0.42%	5,657,523 Common Stock
Nov 09 2020	SELL Open market or private sale	$183,979 $33.06 p/Share	5,565 Reduced 0.1%	5,681,344 Common Stock
Nov 06 2020	SELL Open market or private sale	$90,710 $33.13 p/Share	2,738 Reduced 0.05%	5,686,909 Common Stock
Nov 05 2020	SELL Open market or private sale	$259,100 $33.15 p/Share	7,816 Reduced 0.14%	5,689,647 Common Stock
Nov 04 2020	SELL Open market or private sale	$73,173 $33.14 p/Share	2,208 Reduced 0.04%	5,697,463 Common Stock
Oct 27 2020	SELL Open market or private sale	$23,352 $33.03 p/Share	707 Reduced 0.01%	5,699,671 Common Stock
Oct 26 2020	SELL Open market or private sale	$238,361 $33.3 p/Share	7,158 Reduced 0.13%	5,700,378 Common Stock
Oct 19 2020	SELL Open market or private sale	$124,995 $33.43 p/Share	3,739 Reduced 0.07%	5,707,536 Common Stock
Oct 16 2020	SELL Open market or private sale	$258,388 $33.57 p/Share	7,697 Reduced 0.13%	5,711,275 Common Stock
Oct 15 2020	SELL Open market or private sale	$81,683 $33.03 p/Share	2,473 Reduced 0.04%	5,718,972 Common Stock
Oct 14 2020	SELL Open market or private sale	$160,784 $33.09 p/Share	4,859 Reduced 0.08%	5,721,445 Common Stock
Oct 13 2020	SELL Open market or private sale	$346,254 $33.39 p/Share	10,370 Reduced 0.18%	5,726,304 Common Stock
Oct 12 2020	SELL Open market or private sale	$11,688 $33.11 p/Share	353 Reduced 0.01%	5,736,674 Common Stock
Oct 09 2020	SELL Open market or private sale	$113,030 $33.67 p/Share	3,357 Reduced 0.06%	5,737,027 Common Stock

Also insider at

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC